First Trust NYSE Arca Biotechnology ETF (FBT.TO)
24.74
-1.12
(-4.33%)
CAD |
TSX |
Apr 26, 13:27
Price Chart
Key Stats
Net Expense Ratio | Discount or Premium to NAV | Total Assets Under Management | 30-Day Average Daily Volume |
---|---|---|---|
0.73% | 5.74% | 1.712M | 36.67 |
Dividend Yield | Turnover Ratio | 1 Year Fund Level Flows | Max Drawdown (Since Inception) |
0% | 11.60% | -774751.0 | Upgrade |
Basic Info
Investment Strategy | |
The fund will seek to replicate, to the extent possible, the performance of an index of U.S. companies in the biotechnology industry, initially the NYSE Arca Biotechnology IndexSM. The NYSE Arca Biotechnology IndexSM is an equal dollar weighted index designed to measure the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services. |
General | |
Security Type | Exchange-Traded Fund |
Equity Style | Mid Cap/Growth |
Fixed Income Style | -- |
Broad Asset Class | -- |
Broad Category | Equity |
Category Name | Sector Equity |
Category Index | Morningstar Gbl GR CAD |
Global Category Name | Equity Miscellaneous |
YCharts Categorization | Other |
YCharts Benchmark | S&P 500 Total Return (^SPXTR) |
Prospectus Objective | -- |
Fund Owner Firm Name | FT Portfolios Canada Co |
Prospectus Benchmark Index | |
NYSE Arca Biotechnology TR USD | 100.0% |
Broad Asset Class Benchmark Index | |
^SPTSX60TR | 100.0% |
Manager Tenure | |
Not Disclosed | 9.43 yrs |
Performance Versus Category
As of April 25, 2024. Returns for periods of 1 year and above are annualized.
Annual Total Returns Versus Peers
As of April 25, 2024.
Basic Info
Investment Strategy | |
The fund will seek to replicate, to the extent possible, the performance of an index of U.S. companies in the biotechnology industry, initially the NYSE Arca Biotechnology IndexSM. The NYSE Arca Biotechnology IndexSM is an equal dollar weighted index designed to measure the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services. |
General | |
Security Type | Exchange-Traded Fund |
Equity Style | Mid Cap/Growth |
Fixed Income Style | -- |
Broad Asset Class | -- |
Broad Category | Equity |
Category Name | Sector Equity |
Category Index | Morningstar Gbl GR CAD |
Global Category Name | Equity Miscellaneous |
YCharts Categorization | Other |
YCharts Benchmark | S&P 500 Total Return (^SPXTR) |
Prospectus Objective | -- |
Fund Owner Firm Name | FT Portfolios Canada Co |
Prospectus Benchmark Index | |
NYSE Arca Biotechnology TR USD | 100.0% |
Broad Asset Class Benchmark Index | |
^SPTSX60TR | 100.0% |
Manager Tenure | |
Not Disclosed | 9.43 yrs |